Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
22.68
-0.12 (-0.53%)
At close: Oct 17, 2025, 4:00 PM EDT
22.24
-0.44 (-1.94%)
After-hours: Oct 17, 2025, 5:14 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $694.21 million as of October 17, 2025. Its market cap has increased by 8.44% in one year.
Market Cap
694.21M
Enterprise Value
-75.26M
1-Year Change
8.44%
Ranking
Category
Stock Price
$22.68
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $694.21M, an increase of 343.59%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 694.20M | 22.89% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |